GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Steminent Biotherapeutics Inc (ROCO:7729) » Definitions » PS Ratio

Steminent Biotherapeutics (ROCO:7729) PS Ratio : (As of Dec. 14, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Steminent Biotherapeutics PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Steminent Biotherapeutics's share price is NT$22.45. Steminent Biotherapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was NT$0.00. Hence, Steminent Biotherapeutics's PS Ratio for today is .

Good Sign:

Steminent Biotherapeutics Inc stock PS Ratio (=1382.35) is close to 1-year low of 1250

The historical rank and industry rank for Steminent Biotherapeutics's PS Ratio or its related term are showing as below:

ROCO:7729' s PS Ratio Range Over the Past 10 Years
Min: 1250   Med: 1572.06   Max: 2002.94
Current: 1343.46

During the past 4 years, Steminent Biotherapeutics's highest PS Ratio was 2002.94. The lowest was 1250.00. And the median was 1572.06.

ROCO:7729's PS Ratio is ranked worse than
96.85% of 1015 companies
in the Biotechnology industry
Industry Median: 8.69 vs ROCO:7729: 1343.46

Steminent Biotherapeutics's Revenue per Sharefor the six months ended in Jun. 2024 was NT$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was NT$0.00.

Warning Sign:

Steminent Biotherapeutics Inc revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Steminent Biotherapeutics was -100.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was -73.60% per year.

During the past 4 years, Steminent Biotherapeutics's highest 3-Year average Revenue per Share Growth Rate was -73.60% per year. The lowest was -73.60% per year. And the median was -73.60% per year.

Back to Basics: PS Ratio


Steminent Biotherapeutics PS Ratio Historical Data

The historical data trend for Steminent Biotherapeutics's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steminent Biotherapeutics PS Ratio Chart

Steminent Biotherapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
PS Ratio
- - - -

Steminent Biotherapeutics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PS Ratio Get a 7-Day Free Trial - - - - -

Competitive Comparison of Steminent Biotherapeutics's PS Ratio

For the Biotechnology subindustry, Steminent Biotherapeutics's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Steminent Biotherapeutics's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Steminent Biotherapeutics's PS Ratio distribution charts can be found below:

* The bar in red indicates where Steminent Biotherapeutics's PS Ratio falls into.



Steminent Biotherapeutics PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Steminent Biotherapeutics's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=22.45/0
=

Steminent Biotherapeutics's Share Price of today is NT$22.45.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Steminent Biotherapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was NT$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Steminent Biotherapeutics  (ROCO:7729) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Steminent Biotherapeutics PS Ratio Related Terms

Thank you for viewing the detailed overview of Steminent Biotherapeutics's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Steminent Biotherapeutics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No.16,Wenhu Street, Neihu District, Taipei, TWN, 11445
Steminent Biotherapeutics Inc is a international stem cell biopharmaceutical company which has stable and efficient stem cell platform technology, aiming to develop live cell drugs to treat degenerative diseases as well as acute and life-threatening diseases. With its Stemchymal which is proprietary technology platform generating the standardized, clinical grade, allogeneic stem cells isolated from human adipose tissue. It is operated in strict compliance to regulations of Taiwan, the US, and Japan.

Steminent Biotherapeutics Headlines

No Headlines